FNY Partners Fund LP Has $798,000 Position in Alere Inc. (ALR)

FNY Partners Fund LP boosted its stake in Alere Inc. (NYSE:ALR) by 16,650.0% during the first quarter, Holdings Channel reports. The institutional investor owned 20,100 shares of the medical research company’s stock after buying an additional 19,980 shares during the period. FNY Partners Fund LP’s holdings in Alere were worth $798,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the company. Asset Management One Co. Ltd. raised its position in Alere by 0.5% in the first quarter. Asset Management One Co. Ltd. now owns 15,940 shares of the medical research company’s stock valued at $633,000 after buying an additional 79 shares in the last quarter. Pacer Advisors Inc. raised its position in Alere by 3.0% in the first quarter. Pacer Advisors Inc. now owns 10,810 shares of the medical research company’s stock valued at $429,000 after buying an additional 319 shares in the last quarter. State Board of Administration of Florida Retirement System raised its position in Alere by 0.4% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 130,986 shares of the medical research company’s stock valued at $5,105,000 after buying an additional 545 shares in the last quarter. Bank of New York Mellon Corp raised its position in Alere by 0.7% in the first quarter. Bank of New York Mellon Corp now owns 391,002 shares of the medical research company’s stock valued at $15,535,000 after buying an additional 2,583 shares in the last quarter. Finally, Alambic Investment Management L.P. raised its position in Alere by 48.1% in the first quarter. Alambic Investment Management L.P. now owns 8,000 shares of the medical research company’s stock valued at $318,000 after buying an additional 2,600 shares in the last quarter. Institutional investors and hedge funds own 90.67% of the company’s stock.

Institutional Ownership by Quarter for Alere (NYSE:ALR)

Shares of Alere Inc. (ALR) traded down 0.12% during trading on Friday, reaching $50.17. 1,168,548 shares of the company were exchanged. The stock’s market capitalization is $4.38 billion. The stock has a 50-day moving average of $48.99 and a 200 day moving average of $42.58. Alere Inc. has a 52-week low of $31.47 and a 52-week high of $50.30.

ILLEGAL ACTIVITY NOTICE: “FNY Partners Fund LP Has $798,000 Position in Alere Inc. (ALR)” was originally reported by sleekmoney and is the sole property of of sleekmoney. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://sleekmoney.com/fny-partners-fund-lp-has-798000-position-in-alere-inc-alr/1935378.html.

Several equities analysts have recently commented on the stock. Jefferies Group LLC lowered their price target on shares of Alere from $56.00 to $51.00 and set a “hold” rating for the company in a research report on Monday, April 17th. Craig Hallum lowered shares of Alere from a “buy” rating to a “hold” rating in a research report on Monday, May 15th. Canaccord Genuity restated a “buy” rating and set a $51.00 price target (down previously from $52.00) on shares of Alere in a research report on Monday, April 17th. BTIG Research restated a “hold” rating on shares of Alere in a research report on Wednesday, May 24th. Finally, Zacks Investment Research lowered shares of Alere from a “hold” rating to a “strong sell” rating in a research report on Wednesday, April 19th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. Alere currently has an average rating of “Hold” and an average target price of $49.60.

Alere Company Profile

Alere Inc is a provider of health information through diagnostic tests. The Company’s segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus.

Want to see what other hedge funds are holding ALR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alere Inc. (NYSE:ALR).

This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/fny-partners-fund-lp-has-798000-position-in-alere-inc-alr/1935378.html

Receive News & Ratings for Alere Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alere Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *